Former Senator Ben Sasse Announces Stage-Four Pancreatic Cancer Diagnosis, Shares Poignant Reflections
Former U.S. Senator Ben Sasse shares a deeply personal update, announcing his diagnosis with metastatic stage-four pancreatic cancer and offering reflections on faith, life, and his resolve to fight. Learn more about his journey.

Admin
Former Senator Ben Sasse Announces Stage-Four Pancreatic Cancer Diagnosis, Shares Poignant Reflections
Dec 24, 2025
Former U.S. Senator Ben Sasse Announces Stage-Four Pancreatic Cancer Diagnosis
Former U.S. Senator Ben Sasse, who represented Nebraska in the Senate from 2015 to 2023, has delivered a profoundly personal and somber public statement: he has been diagnosed with metastatic, stage-four pancreatic cancer. In a candid and lengthy social media post, Sasse described the prognosis as a 'death sentence,' a revelation that has garnered significant attention and an outpouring of public support for the former lawmaker.
A Candid Revelation and Philosophical Outlook
Taking to X (formerly Twitter), Sasse, 53, shared the difficult news directly with his followers. He confirmed the advanced nature of his condition, stating, 'Last week I was diagnosed with metastasized, stage-four pancreatic cancer, and am gonna die.' Acknowledging the grim reality of advanced pancreatic cancer, he characterized it as 'nasty stuff' and reiterated its 'death sentence' nature. However, Sasse quickly pivoted to a more philosophical perspective, adding, 'But I already had a death sentence before last week too — we all do,' reflecting on universal mortality.
A devoted family man, Sasse shares three children with his wife. His faith, rooted in his Lutheran upbringing and current Presbyterian affiliation, plays a significant role in his outlook. He specifically noted the timing of his announcement during the Advent season, explaining, 'As a Christian, the weeks running up to Christmas are a time to orient our hearts toward the hope of what's to come.' Despite the challenging road ahead, Sasse expressed his fighting spirit, asserting, 'I'm not going down without a fight,' and indicated that he plans to share more updates in the future.
Ben Sasse's Enduring Political Legacy: The Trump Impeachment Vote
Beyond his recent health update, Ben Sasse's eight-year tenure in the U.S. Senate is often remembered for his independent voice and, notably, his vote during President Donald Trump's second impeachment trial. A distinguished alumnus of both Harvard and Yale Universities, Sasse frequently expressed critiques of Trump's conduct, even while supporting some of his administration's key policy initiatives.
In the wake of the January 6, 2021, Capitol riot, Sasse made a principled stand, becoming one of only seven Republicans to vote in favor of convicting President Trump for incitement of insurrection. While the Senate ultimately did not approve removing Trump from office – a conviction that would have barred him from future presidential bids – Sasse's vote was a powerful affirmation of his beliefs. Explaining his decision at the time, he emphasized the critical need for institutional integrity:
"A weak and timid Congress will increasingly submit to an emboldened and empowered presidency. That's unacceptable. This institution needs to respect itself enough to tell the executive that some lines cannot be crossed."
This pivotal vote remains a defining aspect of his political career.
From Capitol Hill to University President: A Post-Senate Chapter
After concluding his service in the Senate, Sasse embarked on a new chapter, accepting the presidency of the University of Florida. His leadership at the university, however, was relatively brief, concluding in July 2024. Sasse cited pressing family matters as the reason for his departure, specifically the health needs of his wife, who had recently experienced a stroke.
This period also brought a degree of controversy. A review conducted by the Florida Auditor General subsequently flagged certain university funds spent during Sasse's tenure as inappropriate. However, Sasse has consistently maintained his position that his expenditures were entirely appropriate and within university guidelines.